Toggle light / dark theme

Philadelphia, PA, USA / Moscow, Russia — Bioquark, Inc., (http://www.bioquark.com) a life sciences company focused on the development of novel bio-products for regeneration, disease reversion, and healthy aging, announced the commercial approval of naturally derived Bioquantine food ingredients in the Eurasian Customs Union (formerly known as the Customs Union of Belarus, Kazakhstan, and Russia). Moscow based, Lakmus LLC, a diversified investment company with business interests in pharmacies, restaurants, and real estate, collaborated with Bioquark Inc. on the regulatory approvals.

green-cell

“We are very excited about this successful regulatory approval,” said Ira S. Pastor, CEO, Bioquark Inc. “The commercialization of Bioquantine food ingredients, including functional foods, drinks, and dietary supplements, represents another important step in our continued evolution as a company focused on a broad range of products and services in the regenerative healthcare space.”

Throughout the 20th century, natural products formed the basis for a majority of all pharmaceuticals, biologics, and consumer healthcare products used by patients around the globe, generating trillions of dollars of wealth. However, many scientists believe we have only touched the surface with what the natural world, and its range of organisms, which from a health and wellness perspective are much further advanced than human beings, has to teach us.

gene-sequencing

The integration of a complex set of newer research disciplines, including interkingdom signaling, semiochemical communication, and evolutionary biology, as well as significant recent activity in the areas of the microbiome and virome, are highlighting a myriad of new ways that non-human bio-products can affect the human genome for positive transitions in health and wellness dynamics.

“Bioquark has spent several years studying the natural ability of many species to turn back biological time in order to maintain health, fitness, and survival,” said Dr. Sergei Paylian, Founder, CSO, and President, Bioquark Inc. “This Eurasian initiative is one more step in the path in allowing humans to recapture these capabilities to effectively counter our unfortunate progression into aging, disease and degeneration.”

bqaproduction

About Bioquark, Inc.

Bioquark Inc. is focused on the development of natural biologic based products, services, and technologies, with the goal of curing a wide range of diseases, as well as effecting complex regeneration. Bioquark is developing both biological pharmaceutical candidates, as well as products for the global consumer health and wellness market segments.

Link to Press — http://www.prweb.com/releases/2017/01/prweb13955162.htm

“I’m a political theory researcher at Sciences Po, and this talk draws on modern political theories of liberalism, the latest transhumanist literature, and ancient Greek theories of the good life.”


The Transhumanist Paradox.

Deciding between technological utopias in a liberal state.

How does a pluralist society – a society built to accommodate our irreconcilable differences – make a choice about the technological future of mankind? How can a liberal state dedicated to upholding individual liberty interfere in technological progress, and why should it?

Do we really want to leave our technological futures in the hands of the major AI researchers – Google, Facebook, and the US Defense Department?

New version of this out: https://www.geneticliteracyproject.org/2017/01/02/americas-r…-cold-war/ #transhumanism #biohacking


Unlike other epic scientific advances…the immediate effect of genetic editing technology is not dangerous. Yet, it stands to be just as divisive to humans as the 70-year proliferation of nuclear weaponry.

The playing field of geopolitics is pretty simple: If China or another country vows to increase its children’s intelligence via genetic editing, and America chooses to remain “au naturel” because they insist that’s how God made them, a conflict species-deep will quickly arise.

This type of idea takes racism and immigration to a whole new level. Will America close off its borders, its jobs, its schools, and its general openness to the world to stay pure, old-fashioned human?

In short, will genetic editing start a new cold war? One that bears much finger pointing and verbal reprimands, including the use of derogatory terms like mutants, cyborgs, and transhumanists.

Read more

I’m excited to have my #transhumanism interview included in Marc Fennell’s favorite 2016 interviews, with lots of other people like Matt Damon, Quentin Tarantino, Jodie Foster, Steve Wozniak, the South Park creators, etc. Marc Fennell is one of Australia’s favorite tv journalists:


These interviews are the most fun thing I do. I love getting lost in someone’s work, I love editing them and I love getting to show them to you. Here is my 2015 list.

Read more

The National Review via Wesley J. Smith commenting on my “AI Day replacing Christmas” story: http://www.nationalreview.com/corner/443337/ai-day-supplent-christmas #transhumanism #robots #future #AI


Scrooge’s Ghost of Christmas Yet to Come never saw this coming.

The transhumanist popularizer and pseudo presidential candidate, Zoltan Istvan, claims that “AI Day” will soon replace Christmas as the world’s most beloved holiday. From his piece in the Huffington Post:

One thing is for sure, to the human species, the birth of an advanced artificial intelligence will become far more important than the birth of Christ.

Read more

“Bankers will become dinosaurs.” #AI article from The Guardian. https://www.theguardian.com/technology/2016/dec/22/bridgewat…management #Transhumanism


The company is already highly data-driven, with meetings recorded and staff asked to grade each other throughout the day using a ratings system called “dots”. The Systematized Intelligence Lab has built a tool that incorporates these ratings into “Baseball Cards” that show employees’ strengths and weaknesses. Another app, dubbed The Contract, gets staff to set goals they want to achieve and then tracks how effectively they follow through.

These tools are early applications of PriOS, the over-arching management software that Dalio wants to make three-quarters of all management decisions within five years. The kinds of decisions PriOS could make include finding the right staff for particular job openings and ranking opposing perspectives from multiple team members when there’s a disagreement about how to proceed.

The machine will make the decisions, according to a set of principles laid out by Dalio about the company vision.

“It’s ambitious, but it’s not unreasonable,” said Devin Fidler, research director at the Institute For The Future, who has built a prototype management system called iCEO. “A lot of management is basically information work, the sort of thing that software can get very good at.”

Read more